Furthermore, recent studies have demonstrated that strain imaging can predict survival and therapy response in AL amyloidosis in general41–45 while our data further suggest that global longitudinal strain in combination with NT-proBNP may offer a useful survival risk stratification for AL amyloidosis patients with cardiac involvement in particular. This evidence concerns the gene NPPB and AL amyloidosis.